Inhalation April 2024 41
logic Pharmaceuticals—e Out-
come of a Cross-Industry Working
Group Survey. Toxicologic Pathol-
ogy, February;49(2):261-285.
For more information, please con-
tact the corresponding authors: Ben
Forbes, ben.forbes@kcl.ac.uk, Jo
Kilgour, joanne.kilgour@regulatory
science.com and Simon Moore,
simon.moore@labcorp.com.
derived-pharmaceuticals-scientific-
guideline.
3. Alexander DJ, Collins CJ,
Coombs DW, et al. (2008) Asso-
ciation of Inhalation Toxicologists
(AIT) Working Party for Standard
Delivered Dose Calculation and
Expression in Non-Clinical Aero-
sol Inhalation Toxicology Studies
with Pharmaceuticals. Inhalation
Toxicology, 20:1179-1189.
4. Jones, DR, Baldrick P. (2013)
Association of Inhalation Toxicol-
ogists (AIT) Review of Regulatory
Aspects for Inhalation Toxicology
Studies. Inhalation Toxicology,
25:84-90.
5. Forbes B, O'Lone R, Allen
PP, et al. (2014) Challenges for
Inhaled Drug Discovery and
Development: Induced Alveolar
Macrophage Responses. Advanced
Drug Delivery Reviews, 71:15-33.
6. Wolfreys A, Kilgour D, Moore
S, et al. (2021) Review of the Tech-
nical, Toxicological, and PKPD
Considerations for Conducting
Inhalation Toxicity Studies on Bio-
ADVERTISER INDEX
B
Bespak 9
Biomerics 7
Broughton 25
C
Copley Scientific 3
D
DDL 27
I
Intertek Cover 2
M
MKON 13
MSP 29
P
Proveris 5
Q
Qualicaps 17
R
RDD 1
S
S-Matrix 8
2024 ONLINE REFERENCE
& BUYER'S RESOURCE
This valuable resource from Inhalation provides a compilation of organizations,
suppliers, products and services that support the research, development and
manufacturing of inhaled pharmaceuticals.
DOWNLOAD IT NOW INHALATIONMAG.COM
